No connection

Search Results

BFLY vs JNJ

BFLY
Butterfly Network, Inc.
NEUTRAL
Price
$4.51
Market Cap
$1.14B
Sector
Healthcare
AI Confidence
65%
JNJ
Johnson & Johnson
NEUTRAL
Price
$244.85
Market Cap
$590.06B
Sector
Healthcare
AI Confidence
90%

Valuation

P/E Ratio
BFLY
--
JNJ
22.22
Forward P/E
BFLY
-32.8
JNJ
19.48
P/B Ratio
BFLY
5.59
JNJ
7.23
P/S Ratio
BFLY
12.88
JNJ
6.26
EV/EBITDA
BFLY
-16.66
JNJ
18.27

Profitability

Gross Margin
BFLY
62.92%
JNJ
68.08%
Operating Margin
BFLY
-69.69%
JNJ
23.97%
Profit Margin
BFLY
-90.31%
JNJ
28.46%
ROE
BFLY
-41.42%
JNJ
35.03%
ROA
BFLY
-14.35%
JNJ
8.68%

Growth

Revenue Growth
BFLY
4.5%
JNJ
9.1%
Earnings Growth
BFLY
--
JNJ
48.6%

Financial Health

Debt/Equity
BFLY
0.1
JNJ
0.6
Current Ratio
BFLY
4.8
JNJ
1.03
Quick Ratio
BFLY
3.35
JNJ
0.69

Dividends

Dividend Yield
BFLY
--
JNJ
2.13%
Payout Ratio
BFLY
0.0%
JNJ
46.6%

AI Verdict

BFLY NEUTRAL

Butterfly Network (BFLY) shows a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive bankruptcy risk assessment. Despite deeply negative profitability metrics—including a -90.31% profit margin and negative ROE/ROA—the company maintains strong liquidity (Current Ratio: 4.80) and a low Debt/Equity ratio of 0.10. Revenue growth is modest at 4.50% YoY, but earnings surprises have been consistently positive in recent quarters, suggesting operational improvements. However, aggressive insider selling worth $21.71M over the past six months contradicts the 'strong_buy' analyst consensus and raises concerns about insider confidence.

Strengths
Strong liquidity position with Current Ratio of 4.80 and Quick Ratio of 3.35
Low leverage with Debt/Equity ratio of 0.10, well below sector average of 2.28
High gross margin of 62.92%, indicating pricing power or efficient production
Risks
Piotroski F-Score of 5 indicates borderline financial stability; not strong enough to signal robust health
Severe unprofitability: -90.31% profit margin and -41.42% ROE suggest ongoing fundamental weaknesses
Negative Forward P/E of -32.80 implies no near-term earnings recovery priced in
JNJ NEUTRAL

JNJ shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.

Strengths
Strong profitability (28.5% margin)
Strong ROE of 35.0%
Risks
Premium vs Graham Number ($91.63)
Weak financial trend (Piotroski F-Score: 3/9)

Compare Another Pair

BFLY vs JNJ: Head-to-Head Comparison

This page compares Butterfly Network, Inc. (BFLY) and Johnson & Johnson (JNJ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile